Sign in

Laura Dolbow

@lauradolbow.bsky.social
354 followers 179 following 1 posts

Associate Professor of Law at Colorado Law. Writing about patents and regulation of the pharmaceutical industry

PostsRepliesMedia
Reposted by Laura Dolbow
Bridget Dooling @bridgetdooling.bsky.social · 11/11/2025
NEWS! The ABA Admin Law Conference is FREE this year, in light of the shutdown. Great for admin law practitioners, academics, and students. It'll be Nov. 21 but you'll also be able to access recordings for 30 days afterwards. 6 FREE hours of CLE (approvals pending), including 3 ethics hours:
events.americanbar.org
2025 Administrative Law Fall Conference
22715
Reposted by Laura Dolbow
Chris Morten @cmorten.bsky.social · 13/10/2025
🚨 New from the Science, Health & Information Clinic at @nyulaw.bsky.social! 🚨 An amicus brief in Vanda v. United States, on federal agencies' legal authority to use & disclose private trade secrets. A case you probably haven't heard of, but with major consequences for federal regulation! 🧵 1/
1116
Reposted by Laura Dolbow
The Regulatory Review @theregreview.bsky.social · 21/07/2025
The Supreme Court’s unanimous decision in FDA v. Wages & White Lion Investments "provided some clarity on the harmless error rule for agency decisions," but "left several important administrative law issues unresolved," @lauradolbow.bsky.social observes. www.theregreview.org/2025/07/21/d...
011
Reposted by Laura Dolbow
Lisa L. Ouellette @patentscholar.bsky.social · 04/07/2025
Among many harmful effects of this bill, cutting Medicaid not only has immediate health impacts—it also further decreases R&D incentives for health issues that disproportionately impact low-income Americans. See @rachelsachs.bsky.social, Prizing Insurance (2016) jolt.law.harvard.edu/assets/artic...
jolt.law.harvard.edu
194
Laura Dolbow @lauradolbow.bsky.social · 13/05/2025
So excited to see Public Patent Powers live on the @michlawreview.bsky.social website! Thanks again to the editors for all the hard work!
040